Expanded Access Statement

Expanded Access Statement

At Orexigen, we believe in the value of ongoing scientific innovation and its potential to transform patientsā€™ lives.

The Role of Expanded Access Programs

The most efficient and effective method of making new medicines available to patients is by conducting well-designed clinical trials. For patients with serious or life-threatening diseases, we believe that expanded access programs may provide an appropriate forum for them to access investigational medicines in certain circumstances.

Our Perspective

Given the early stage of our investigational medicines, we have not formalized a policy on expanded access at this time. We intend to regularly re-assess our approach as the status of our early development programs evolve. If you have any questions, please contact This email address is being protected from spambots. You need JavaScript enabled to view it. .